Evidence map›Paper›PMID 41060588›Full record

ArticleApplied biochemistry and biotechnology2025

Xylonic Acid Production from Sugarcane Bagasse Hydrolysate Using an Engineered Komagataella phaffii Strain.

Isabela Castro de Almeida, João Ricardo M Almeida, Fabricio Machado, Sílvia Belém Gonçalves

Abstract read
PubMed Publisher
In one paragraph

Article in Applied biochemistry and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Isabela Castro de AlmeidaInstituto de Química, Universidade de Brasília, Campus Universitário Darcy Ribeiro, 70910-900, Brasília, DF, Brazil.
João Ricardo M AlmeidaEmbrapa Agroenergia, Parque Estação Biológica, PqEb S/N, W3 Norte, 70770-901, Brasília, DF, Brazil.
Fabricio MachadoInstituto de Química, Universidade de Brasília, Campus Universitário Darcy Ribeiro, 70910-900, Brasília, DF, Brazil.
Sílvia Belém GonçalvesEmbrapa Agroenergia, Parque Estação Biológica, PqEb S/N, W3 Norte, 70770-901, Brasília, DF, Brazil. silvia.belem@embrapa.br.ORCID http://orcid.org/0000-0002-6036-4725

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Xylonic acid is an oxidized derivative of xylose that is used by the food, pharmaceutical, and chemical industries. It can be produced either microbially or chemically. Biological production is advantageous because of its safety, eco-friendliness, and mild process conditions. This study used a recombinant Komagataella phaffii strain modified to produce xylonic acid from xylose. Glucose and glycerol were evaluated as co-substrates in batch and fed-batch fermentations in flasks and in bioreactor cultures. Glycerol was an effective carbon source for improving growth and product production. Batch fermentations with glycerol produced 24.88 ± 1.64 g.L

Indexed as

CelluloseSaccharomycetalesSaccharumSugar AcidsBioreactorsFermentationGlucoseGlycerolHydrolysisXylosebagasseCelluloseGlucoseGlycerolSugar Acidsxylonic acidXyloseHydrolysateKomagataella phaffiiSugarcane bagasseXylonic acid

Identifiers

PMID41060588

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.